LMRI
Lumexa Imaging·NASDAQ
--
--(--)
--
--(--)
LMRI fundamentals
Lumexa Imaging (LMRI) released its earnings on Mar 26, 2026: revenue was 260.65M (YoY --), missed estimates; EPS was 0.0605 (YoY --), beat estimates.
Revenue / YoY
260.65M
--
EPS / YoY
0.0605
--
Report date
Mar 26, 2026
LMRI Earnings Call Summary for Q4,2025
- Strong Q4 Performance: Revenue +7.9%, EBITDA +18.6%, driven by advanced imaging and Fast Scan adoption.
- 2026 Growth Plan: 8-10 new centers, expansion of BAC and PET services, AI-driven efficiency gains.
- Financial Strength: Leverage reduced to 3.5x, $50M annual interest savings, and 2026 EBITDA guidance of +5-7%.
- Q1 Challenges: Flat EBITDA due to weather and volume pull-forward, but confident in full-year recovery.
- Innovation Focus: AI partnerships, Virtual Cockpit, and 66% Fast Scan adoption by year-end.
EPS
Actual | 0.0605 |
Forecast | 0.0455 |
Surprise | +32.97% |
Revenue
Actual | 260.65M |
Forecast | 261.17M |
Surprise | -0.20% |
Earnings Call
You can ask Aime
What guidance did Lumexa Imaging's management provide for the next earnings period?What is the revenue and EPS growth rate for Lumexa Imaging year over year?What is Lumexa Imaging's gross profit margin?What were the key takeaways from Lumexa Imaging's earnings call?What is Lumexa Imaging's latest dividend and current dividend yield?What were the key takeaways from Lumexa Imaging’s earnings call?Did Lumexa Imaging beat or miss consensus estimates last quarter?What factors drove the changes in Lumexa Imaging's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
